Publikationen, an denen er mitarbeitet Xabier de Aretxabala (10)

2023

  1. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat

    Frontiers in Neuroanatomy, Vol. 16

2021

  1. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

2020

  1. Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice

    Neuropsychopharmacology, Vol. 45, Núm. 2, pp. 309-318

2019

  1. Ketaminaren eragin antidepresiboak. Ekintzamekanismo berriak farmako antidepresiboen bilaketarako

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 35, pp. 41-56

2016

  1. Data for the morphometric characterization of NT2-derived postmitotic neurons

    Data in Brief

  2. Highly efficient generation of glutamatergic/cholinergic NT2-derived postmitotic human neurons by short-term treatment with the nucleoside analogue cytosine β-d-arabinofuranoside

    Stem Cell Research, Vol. 16, Núm. 2, pp. 541-551

2015

  1. Nuclear diacylglycerol lipase-α in rat brain cortical neurons: Evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity

    Journal of Neurochemistry, Vol. 132, Núm. 5, pp. 489-503

2014

  1. Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons

    Advances in Biological Regulation, Vol. 54, Núm. 1, pp. 12-23

2013

  1. Sistema endokannabinoidea: etorkizun handiko itu terapeutikoa gaixotasun psikiatrikoetan

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 1, pp. 115-127